ERBB2 and neoplasm: Instead, a significant higher response rate was observed for the HER2-single-type compared to the Luminal-HER2-type, after correcting for HR status, tumor stage, tumor grade, and therapy in a multivariate logistic regression analysis (p value = 0.006, Table S2).